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Abstract
Every protein has a biosynthetic cost to the cell based on the synthesis of its constituent amino acids. In order to optimise
growth and reproduction, natural selection is expected, where possible, to favour the use of proteins whose constituents
are cheaper to produce, as reduced biosynthetic cost may confer a fitness advantage to the organism. Quantifying the cost
of amino acid biosynthesis presents challenges, since energetic requirements may change across different cellular and
environmental conditions. We developed a systems biology approach to estimate the cost of amino acid synthesis based on
genome-scale metabolic models and investigated the effects of the cost of amino acid synthesis on Saccharomyces
cerevisiae gene expression and protein evolution. First, we used our two new and six previously reported measures of amino
acid cost in conjunction with codon usage bias, tRNA gene number and atomic composition to identify which of these
factors best predict transcript and protein levels. Second, we compared amino acid cost with rates of amino acid
substitution across four species in the genus Saccharomyces. Regardless of which cost measure is used, amino acid
biosynthetic cost is weakly associated with transcript and protein levels. In contrast, we find that biosynthetic cost and
amino acid substitution rates show a negative correlation, but for only a subset of cost measures. In the economy of the
yeast cell, we find that the cost of amino acid synthesis plays a limited role in shaping transcript and protein expression
levels compared to that of translational optimisation. Biosynthetic cost does, however, appear to affect rates of amino acid
evolution in Saccharomyces, suggesting that expensive amino acids may only be used when they have specific structural or
functional roles in protein sequences. However, as there appears to be no single currency to compute the cost of amino
acid synthesis across all cellular and environmental conditions, we conclude that a systems approach is necessary to unravel
the full effects of amino acid biosynthetic cost in complex biological systems.
Citation: Barton MD, Delneri D, Oliver SG, Rattray M, Bergman CM (2010) Evolutionary Systems Biology of Amino Acid Biosynthetic Cost in Yeast. PLoS ONE 5(8):
e11935. doi:10.1371/journal.pone.0011935
Editor: Ju ¨rg Ba ¨hler, University College London, United Kingdom
Received February 9, 2010; Accepted May 21, 2010; Published August 17, 2010
Copyright:  2010 Barton et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by Natural Environment Research Council Ph.D. studentship NER/S/R/2005/13609 to MDB, Natural Environment Research Council
advanced fellowship NE/B500190/1 to DD, NER/T/S/2001/00343 to SGO, and Biotechnology and Biological Sciences Research Council grant BB/C008219/1 to SGO,
MR, and CMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mail@michaelbarton.me.uk
Introduction
Everything in a living cell has a cost: from the energy needed to
transform molecules against thermodynamic equilibria, to the raw
materials needed to produce the constituents of a new cell. Natural
selection may be expected to minimise such cellular costs, and evidence
for adaptation to require less energy or matter may exist at the
molecular or cellular level. Thist h e o r yi sd e s c r i b e da st h ec o s t
minimisation hypothesis. Testing this hypothesis requires answering
s e v e r a lq u e s t i o n sa b o u tw h a ti st h em e a n i n go fc o s ti nt h ec e l l ,a n dh o w
best to measure it. For example, how does one assign a biochemical
p r i c et oam o l e c u l ew h o s es t a t ei sd e p e n d e n to nc h a n g i n g
environmental and cellular conditions? Similarly, is it possible to
understand the energetic costs required for metabolite synthesis,
independent of other cellular functions? Knowing the answers to these
questions is central to a systematic understanding of the chemical forces
that shape the composition of biomolecules, and how biomolecular
composition relates to protein expression and evolution.
Craig and Weber [1] pioneered the quantitative analysis of cost
at the cellular level to investigate the effects on the synthesis and
evolution of a small number of Escherichia coli proteins. These
authors estimated the cost of a protein as the per-residue average
of how many units of high energy phosphate bonds (e.g. ATP) and
reducing hydrogen atoms (e.g. NADPH) are diverted from the
available energy pool to produce each of the constituent amino
acids from glucose. Akashi and Gojobori [2] used a modified
version of this approach to show in E. coli and Bacillus subtilis that
predicted gene expression levels based on codon usage bias show a
negative correlation with average protein cost. This work provided
the first genome-wide evidence that evolution has optimised
prokaryotic cells to use less expensive amino acids in highly
expressed proteins and established an important link between the
metabolism of a cell and the evolution of its genome sequence.
Heizer et al. [3] extended the findings of Akashi and Gojobori
[2] to four additional prokaryotic species and demonstrated that
metabolic cost optimisation occurs whether the source of energy is
organic or inorganic. Swire [4] used Craig and Weber’s [1] cost
values to generate a new cost measure for an amino acid based on
its usage in proteins as a function of overall protein cost computed
from all other amino acids, and showed that cost selection affects
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[5] developed a method similar to Craig and Weber [1] that
includes the energetic costs of synthesising both mRNA and
protein for Saccharomyces cerevisiae, and showed that the cost of
doubling gene expression after a gene duplication is likely to be
significant enough to be detected by natural selection. More
recently, Raiford et al. [6] compared Wagner’s [5] amino acid
biosynthetic costs with codon bias, transcript levels and protein
levels and observed that cost minimisation is observed across
different functional categories of genes, but that its effects are
restricted to certain amino acids.
Seligmann [7] argued that, while the number of high energy
molecules is an important part of the energetic investment of
synthesising an amino acid, this approach is unlikely to explain the
entire investment made by a cell. Instead, Seligmann [7] used the
molecular weight as a proxy for biosynthetic cost, reasoning that
this may take into account all the manifold effects of producing
larger, more complex amino acids. Molecular weight also has the
advantage of being constant across species, and therefore can be
used to test the cost selection hypothesis where the genome
sequence is available but the pathways for amino acid synthesis are
unknown. Seligmann [7] used this to prove, on an individual
protein basis, that molecular weight is minimised across a range of
bacterial and eukaryotic genomes.
Despite the widespread conservation of amino acid biosynthetic
pathways, using a fixed set of energetic requirements may not
represent the true cost of amino acid synthesis in different cellular
and environmental conditions. For example, Wagner [5] has
shown that the estimated cost of amino acid biosynthesis varies
under different modes of growth (fermentative vs. respiratory). The
cost of amino acid synthesis may also vary as a function of limiting
nutrients in the environment. Thus, developing methods to
investigate the cost of amino acid synthesis under varying
environmental conditions is essential to understanding the impact
of biosynthetic cost on cellular systems. Just as in supply and
demand economics, when a chemical resource is scarce in the cell
or environment, synthesis of biomolecules that require this
resource will be more expensive in comparison to molecules
where that resource is utilised less [8]. As an example of the effect
of supply and demand in cellular economics, Varma et al. [9]
showed in E. coli that the ‘‘shadow price’’ of using molecules
involved in energy production changes according to the
availability of oxygen. As the availability of oxygen decreases,
the cost of its use rises, while the cost of ethanol use decreases as
the energy to reduction-oxidation ratio becomes less efficient.
Likewise, Carlson [8] demonstrated a similar principle of supply
and demand by showing in silico that E. coli will likely favour the
use of cheaper, but less efficient, pathways in stress inducing
environments.
In this report, we use a systems biology approach based on flux
balance analysis (FBA), similar to methods of Varma et al. [9], to
estimate the cost of synthesising amino acids under differing
nutrient availabilities in the environment. We first estimate the
‘‘absolute’’ cost of amino acid synthesis by examining the
sensitivity of nutrient uptake in the cell to small absolute changes
in the stoichiometric requirement of each amino acid for growth in
the FBA model. We then estimate a second ‘‘relative’’ cost by
examining the sensitivity of nutrient uptake to small percentage
changes in the amino acid stoichiometric requirement. We
calculate each of these amino acid cost types for three nutrient
limiting conditions (glucose, ammonia and sulphate) to investigate
how cost varies from environment to environment. We focus our
analysis on protein coding genes, because as in previous studies
[1,3–5,7] this allows us to analyse the effects of biosynthetic cost at
the transcript and protein levels, which we extend here to the
analysis of rates of amino acid substitution across species. The
results in this work show that biosynthetic cost has a small but
measurable relationship with transcript and protein levels,
independent of codon usage bias, per codon tRNA gene number
or protein atomic content. Furthermore, we show that biosynthetic
cost is negatively correlated with rates of amino acid evolution and
conclude that selection for cost minimisation does indeed play a
role in Saccharomyces protein expression and evolution.
Results
A systems biology approach to estimating the cost of
amino acid synthesis
Our analysis uses systems biology to determine the cost of an
amino acid using a model of metabolism that takes into account
many of the requirements for S. cerevisiae cellular growth. This
analysis is based on in silico reconstructions of the reaction
networks comprising cellular metabolism in organisms such as E.
coli and S. cerevisiae. These ‘genome scale models’ are formulated as
a matrix S that describes the connectivity between the hundreds of
reactions in metabolism. Organism metabolic phenotypes can
then be simulated using these models combined with a technique
called flux balance analysis (FBA) reviewed in [10]. FBA uses the
matrix of reactions in a genome scale model to find the optimal
combination of reactions that consume available nutrients (e.g.
glucose and ammonium) to produce the metabolites (e.g. sugars,
fats, high energy molecules) required for new cellular growth (also
described as biomass production).
Our approach to estimating biosynthetic cost simulates small
changes in the demand for an amino acid in cell growth (as part of
the biomass producing reaction) then analyses the corresponding
response in the supply of three nutrients: glucose, ammonium and
sulphate. To simulate a change in amino acid demand, the in silico
requirement for each amino acid was changed by a range of small
values around the original requirement defined in the model. Each
change added a slight increase or decrease in the requirement of
the amino acid for biomass production. Amino acid requirements
were changed at the Sij position in the model stoichiometric
matrix, with position j corresponding to the reaction producing
new biomass components for growth and i corresponding to the
amino acid being examined. For each change in amino acid
requirement, FBA was used to simulate the smallest possible
uptake flux of either glucose, ammonium, or sulphate entering the
cell whilst still maintaining the fixed growth rate. The vector of
changes in amino acid requirement produced a corresponding
vector for the effect each change had on nutrient entry into the
cell. The minimisation of each nutrient entry into the cell aimed to
simulate a limiting environment for that particular nutrient (e.g.
glucose, where all other nutrients including ammonium and
sulphate are in abundance). In our approach, the biomass reaction
is fixed to a constant growth rate and then a specific uptake flux is
minimised. It is of course possible to do the reverse, i.e. fix the
uptake of a specific nutrient and then optimise the biomass flux.
The reason we adopted the fixed growth rate approach is because
this simulation framework mimics the continuous culture of a
chemostat, which is how experimental data on gene expression are
often produced. A useful side effect though is that all simulations
are performed on the same growth rate, which makes them more
easily comparable because they are on the same scale (see below).
Using this approach, two types of amino acid cost were
estimated. The first type was derived from changing each amino
acid requirement by an absolute amount around the original
value, which we refer to as ‘‘absolute’’ amino acid cost. A second
Amino Acid Cost in Yeast
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relative percentage around the original value, which we refer to as
‘‘relative’’ amino acid cost. The relationship between absolute and
relative costs is formally shown in the Methods. In both cases, the
cost of the amino acid was then estimated from the slope of the
simulated effect on nutrient uptake as a function of changing the
amino acid requirement. The greater the change in nutrient
supply with change in amino acid requirement, the steeper the
slope, and therefore the more ‘‘expensive’’ the amino acid.
Absolute and relative costs were computed in three simulated
nutrient limitations, providing us with six estimates of amino acid
cost. To assist in the discussion of these costs we adopted the
convention of Rnutrient and Anutrient for either relative or absolute
costs in each simulated nutrient limitation.
One important consideration for our approach is the model
growth rate at which each cost type was estimated. A common
objective when performing FBA is to determine the maximum
possible growth rate for a genome scale model. Here we instead
aimed to simulate nutrient limitation rather than maximum
growth rate. Therefore, we fixed growth rate to a constant value
and found the FBA solution for the minimum nutrient entry in the
cell. To address the potential dependence of cost on the growth
rate constant, we estimated each amino acid cost at a range of
feasible yeast growth rates (0:1 hr{1, 0:2 hr{1 and 0:3 hr{1) [11].
We indeed found that each cost estimate was proportional to the
growth rate constant at which it was estimated, but that this
dependency could be removed by dividing the cost estimate by
the growth rate at which it was estimated. Using this rescaling,
the variation in cost estimates observed for each cost type
across growth rates was low, with the largest difference in
rescaled costs over the three model growth rates being
0:000537 mmol{1 gDW{1 for the phenylalanine Rglucose cost,
and 0.0145 for the tryptophan Aglucose cost. These results indicate
that our rescaled cost estimates are largely unaffected by model
growth rate. For the purpose of this study, we used the amino acid
costs estimated at a growth rate of 0:3hr{1.
Comparison of systems biology derived biosynthetic
costs with previous estimates
Amino acid biosynthetic costs estimated using our systems
biology method along with those reported previously in the
literature are compared in Table 1 and along the left hand side of
Figure 1. The right hand side of Figure 1 shows a dendrogram
visualising the similarity between our estimated costs with those
previously reported in the literature based on an agglomerative
hierarchical clustering of pairwise Spearman’s rank correlations
between each amino acid cost type. All cost types used in this
analysis are available in Supplementary File S1. The Spearman’s
R and p-values for the correlations between costs are available in
Supplementary File S2.
Under conditions simulating glucose limitation, our Aglucose cost
is clearly correlated with other previously reported measures of
amino acid cost. Aglucose has Spearman correlation coefficients
greater than 0.8 with Akashi and Gojobori’s energetic cost [2],
Craig and Weber’s energetic cost [1], Wagner’s respiratory
energetic cost [5], and molecular weight [7] (Supplementary File
Table 1. Measures of amino acid cost.
Aglucose Rglucose A&G Energy C&W Energy C&W Steps Wager Ferm. Wagner Resp.
Seligmann
Weight
ala 0.50 0.223 11.7 12.5 1 2 14.5 89.1
arg 1.39 0.218 27.3 18.5 10 13 20.5 174.2
asn 0.79 0.078 14.7 4 1 6 18.5 132.1
asp 0.61 0.178 12.7 1 1 3 15.5 133.1
cys 0.75 0.005 24.7 24.5 9 13 26.5 121.2
gln 0.92 0.095 16.3 9.5 2 3 10.5 146.2
glu 0.86 0.254 15.3 8.5 1 2 9.5 147.1
gly 0.31 0.087 11.7 14.5 4 1 14.5 75.1
his 1.46 0.094 38.3 33 1 5 29 155.2
ile 1.21 0.226 32.3 20 11 14 38 131.2
leu 1.21 0.348 27.3 33 7 4 37 131.2
lys 1.31 0.366 30.3 18.5 10 12 36 146.2
met 1.25 0.062 34.3 18.5 9 24 36.5 149.2
phe 1.84 0.240 52.0 63 9 10 61 165.2
pro 0.99 0.159 20.3 12.5 4 7 14.5 115.1
ser 0.49 0.089 11.7 15 3 1 14.5 105.1
thr 0.69 0.128 18.7 6 6 9 21.5 119.1
trp 2.39 0.066 74.3 78.5 12 14 75.5 204.2
tyr 1.77 0.176 50.0 56.5 9 8 59 181.2
val 0.96 0.246 23.3 25 4 4 29 117.2
Rescaled Aglucose cost is unitless and Rglucose cost is in units of mmol{1 gDW{1. The Akashi and Gojobori [2], Craig and Weber energy [1], and the Wagner fermentative
and respiratory costs [5] are based on curation of the number of high-energy molecules used during synthesis, converted to potential high energy phosphate bonds.
The Craig and Weber ‘steps’ measure [1] is based on the number of biosynthetic steps between central metabolism and the resulting amino acid. Amino acid molecular
weight as used by Seligmann [7] is measured in Daltons. All cost estimates are available in Supplementary File S1.
doi:10.1371/journal.pone.0011935.t001
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biosynthetic complexity [1] show lower correlation coefficients of
0.522 and 0.65, respectively. These results indicate Aglucose is in
good agreement with estimates based on manually-curated
measures previously described in the literature. In contrast, our
Rglucose cost shows no significant correlation with any previously
described cost measure (all p w 0:05). The highest Spearman
coefficient between Rglucose and any other literature dataset is
0.077 (p=0.49, with Wagner’s fermentative energetic cost [5]).
This indicates that our Rglucose cost has little in common with
previous formulations of amino acid cost.
Under conditions simulating ammonium- and sulphate-limita-
tion, we find that the Asulphate and Aammonium costs are directly
proportional to the amount of either nitrogen or sulphur atoms in
the amino acid, respectively. In contrast, the Rsulphate and
Rammonium costs reflect both the composition of either sulphur or
nitrogen in the amino acid and the usage of the amino acid in the
reaction producing new biomass for cell growth. The contrast
between the absolute and relative estimates of amino acid cost
under these conditions can be illustrated by the costs for cysteine
and methionine. These two amino acids both contain a single
sulphur atom and therefore the Asulphate cost of each is the same:
one. The Rsulphate cost of methionine however is much greater
than that of cysteine as the proportional use of methionine in the
biomass reaction is greater. One observation of potential interest is
that the Rglucose and Rammonia costs are correlated (Spearman
R ~ 0:63, p ~ 0:003). We speculate that this correlation may
reflect an intrinsic adaptation in amino acid biosynthetic
pathways, as any mutations to minimise biosynthetic cost under
glucose limitation would also minimise the cost of amino acid
synthesis in an ammonium-limited environment.
Comparison of costs in E. coli and S. cerevisiae
Given the relative ease with which amino acid costs can be
calculated using our systems biology method, we estimated Rglucose
and Aglucose costs for E. coli using the iJR904 model [12]
(Supplementary File S3). The aim of this was to demonstrate the
generality of our approach and to explore the similarity of amino
acid biosynthetic cost estimates across species and FBA models.
Our analysis showed the Aglucose costs are highly correlated
between species (Spearman R ~ 0:94, p v ~10{15), as are
Rglucose costs (Spearman R ~ 0:74, p v 0:001). The higher
correlation of Aglucose costs is expected given the conservation of
core metabolic pathways across species [13], whereas the greater
variation in Rglucose costs may arise from species specific variation
in amino acid usage. Overall this demonstrates the general
applicability of our method to any species with a genome-scale
metabolic model.
The cost of amino acid synthesis on the yeast
transcriptome and proteome
Gene expression at the transcript level. If biosynthetic
cost is a selective force acting on cells, we expect to observe a
negative correlation between the biosynthetic cost of the encoded
Figure 1. Comparison of amino acid biosynthetic cost estimates. Amino acid biosynthetic cost estimates are compared in the barcharts on
the left hand side. Similarities among different cost types are visualised as a tree on the right hand side. The closer two cost types are in the tree the
more similar the cost estimates. Each barchart axis shows the minimum and maximum value of each cost type, rounded to three significant figures.
We note that absolute costs computed using our systems biology approach are unitless (see Materials and Methods for details). The cost comparison
dendrogram was generated using complete agglomerative clustering of Spearman’s Rank correlations between each cost type (see File S2).
doi:10.1371/journal.pone.0011935.g001
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investigated the capacity of Aglucose and Rglucose cost (as well as
each previously reported cost measure) to explain gene expression
at the transcript level in the S. cerevisiae dataset of Castrillo et al. [11]
using multivariate regression. The expression of each transcript
was modelled as a function of the mean energetic cost per residue
of the protein, the codon usage bias of the coding sequence
measured by the codon adaptation index (CAI), mean number of
tRNAs per residue, and the mean atomic composition per residue
of the protein. Since codon usage and tRNA number are known to
correlate with each other [14], and codon usage is known to
correlate with both gene expression [14,15] and cost [2], their joint
inclusion in our model allows us to demonstrate an independent
effect of cost that controls for these factors. For this analysis, we
only investigated the explanatory power of our cost measures
estimated under glucose limiting conditions, as this is the
environment thought to be most relevant to yeast biology
[11,16,17]. Table 2 shows the explanatory power for the full
multivariate regression for each cost type in predicting transcript
levels. All regression models explain *40% of the variation in
transcript levels across genes, with the difference in variation
explained by the best and worst being only 4.5%.
Using Akaike’s Information Criterion (AIC) [18] the importance
of the variables in the regression equation was measured by
removing each in turn, then comparing the goodness-of-fit of the
reduced model with the full model containing all terms. Figure 2A
compares the importance of each variable in explaining transcript
levels with other variables in the same regression model for each
cost type. Compared to other characteristics of the encoded
protein, the codon bias of the transcript is at least half an order of
magnitude more important than the nearest explanatory variable,
regardless of which cost type is used. This result supports the well-
established fact that codon bias correlates with gene expression
levels in growing yeast cells [14,15,19,20]. The dominant influence
of codon bias over other factors also explains why the use of
different cost types in the multivariate regression model does not
substantially effect the predictive power. A general trend across all
the regression analyses is that the most important variable after
codon bias is either biosynthetic cost, carbon content or nitrogen
content. The importance of tRNA number on transcript levels
appears relatively constant regardless of which cost is used. Finally
sulphur content appears the least predictive measure of transcript
levels.
Gene expression at the protein level. The importance of
biosynthetic cost in explaining gene expression at the protein level
was also assessed using multivariate regression followed by variable
removal using the same strategy as for transcript levels above. To
analyse the effect of cost on protein levels, we used data from
Ghaemmaghami et al. [21], since protein levels from Castrillo et al.
[11] were measured relative to a background (see Methods for
details). Table 2 illustrates the explanatory power of each
regression model to predict protein levels. As with the transcript
data, each regression model explains *40% of the variation in
protein levels, and the difference in variance explained between
the best and worst model is very small (*0:8%), relative to the
overall variance explained.
Figure 2B shows the relative importance of each factor in the
multivariate regression model for protein expression levels. This
analysis reveals similar trends to that for transcript levels where
codon bias is the most important factor by an order of magnitude.
This result is not surprising given that Ghaemmaghami et al. [21]
previously showed a Spearman’s rank correlation of R ~ 0:57 for
the relationship between CAI and protein abundance. The best
regression fit uses Aglucose, in which biosynthetic cost, carbon
content and nitrogen content all have a similar importance in
explaining variation in protein levels. Protein levels exhibit similar
trends to transcript levels where generally (i.e. across all regression
models) biosynthetic cost, carbon content and nitrogen content all
play a similar importance in explaining variation in gene
expression levels, and sulphur content is the least important.
However the importance of tRNA number and sulphur content
are more variable in explaining protein expression levels and in
some instances their removal improves model parsimony, as
indicated by a reduced AIC.
Biosynthetic cost trends in protein sequence relative
substitution rates
In addition to investigating the potential effects of amino acid
biosynthetic cost on transcript and protein levels, we considered
whether cost minimisation may also affect rates of amino acid
substitution across yeast species. Specifically, we sought to test if
rates of amino acid substitution at a particular site in a protein
showed a negative correlation with amino acid cost, which might
be expected under the cost selection hypothesis if costly amino
acids used at structurally or functionally important sites are
conserved in evolution.
The rate of amino acid substitution per site was estimated at
each position in alignments of protein sequence from four
Saccharomyces species for 3334 genes. Substitution rates at each
site were divided by the estimated tree length across the entire
Table 2. Adjusted R2 coefficients for multiple regression models.
Cost type Transcripts Castrillo et al. 2007 Proteins Ghaemmaghami et al. 2003
S. cerevisiae Aglucose 0.389 0.406
S. cerevisiae Rglucose 0.383 0.408
Akashi & Gojobori (2002) 0.398 0.405
Craig & Weber (1998) Energy 0.416 0.40
Craig & Weber (1998) Steps 0.375 0.404
Wagner (2005) Respiratory 0.382 0.405
Wagner (2005) Fermentative 0.377 0.406
Molecular Weight 0.422 0.405
The R2 describes the fit of each regression with CAI, tRNA gene number, atomic content, and biosynthetic cost explain variation in experimental data. Each row
represents the specific cost estimate used in that regression.
doi:10.1371/journal.pone.0011935.t002
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PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e11935Figure 2. Comparison of factors explaining observed transcript and protein levels in S. cerevisiae. Each point is the contribution of the
variable to explaining either protein or transcript levels. Points to the right have a greater contribution and vice versa for points to the left. Multiple
points are shown for each variable in the figure, one for each cost type used in separate regression models fitted to explain transcript and protein
levels using the following explanatory variables: average per residue protein carbon, nitrogen, sulphur content, average per residue protein
biosynthetic cost, average per codon tRNA gene number and transcript CAI. The contribution of each variable to explaining transcript and protein
data was then estimated by removing the variable from the regression and then estimating the size of the effect on explanatory power measured
using Akaike’s Information Criterion (AIC).
doi:10.1371/journal.pone.0011935.g002
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gene. This rescaling was performed to control for factors that
affect the rate of protein evolution that act at the level of the gene
(e.g. expression level). The single gene alignment with an estimated
tree length of 0 was removed from the analysis. This resulted in
1.66 million substitution rate estimates, one at each individual
alignment column. In addition to the alignment column
substitution rate, the ancestral amino acid at each site was also
predicted. The mean substitution rate was calculated for each
amino acid across all sites where it was inferred in the ancestral
protein and then compared with the S. cerevisiae biosynthetic cost
for that amino acid.
Table 3 shows the correlation of mean substitution rate with
biosynthetic cost for all amino acid cost types. Figure 3 illustrates
the relationship between mean substitution rate and cost for each
amino acid for three different measures of biosynthetic cost that
had a low pairwise Spearman rank correlation (see Table 2):
molecular weight, Rglucose, and Aglucose. As predicted under the
cost selection hypothesis, mean substitution rate is negatively
correlated with some amino acid cost measures, including
molecular weight, Akashi and Gojobori’s energetic cost [2] and
Aglucose biosynthetic cost. However, the Rglucose cost shows no
correlation with mean substitution rate. Overall, Aglucose provides
the best cost estimate to explain variation in substitution rates.
These results suggest that cost minimisation may exert a selective
pressure on rates of protein sequence evolution in Saccharomyces
species and that amino acid cost derived using our systems biology
approach is one of the best variables for explaining this trend. We
hypothesise that this trend is due to expensive amino acids being
conserved at certain sites due to selective constraints on structure
of function, while the choice of amino acids in divergent sites is
more affected by cost selection (see Discussion).
Discussion
The principal outcomes of this work are twofold. First, we
developed a novel method to estimate the cost of amino acid
synthesis using a systems biology approach. Using FBA in the S.
cerevisiae genome scale model we examined the sensitivity of different
nutrient uptakes to changes in amino acid requirement. We
compared our novel estimates of amino acid cost to six previously
reported measures and showed that the absolute cost of amino acid
biosynthesis under glucose limiting conditions (Aglucose) is highly
correlated with previous cost measures, while relative cost under the
same simulated environmental conditions (Rglucose)i sn o t .W e
further showed that our systems biology approach can be applied to
calculate environment-specific biosynthetic costs, which highlighted
the effects of limiting factors in amino acid biosynthesis.
Secondly we investigated the predictive power of our biosynthetic
cost measures in explaining variation in S. cerevisiae transcript and
proteins levels, and explaining rates of amino acid substitution
across four Saccharomyces species. Our analysis shows that biosyn-
thetic cost does show an association with transcript and protein
levels, but explains only a minor component compared with factors
like codon usage bias that are related to translational optimisation.
In contrast, we find that some amino acid cost measures are
correlated with substitution rates in protein coding sequences.
No single currency for amino acid biosynthetic cost
Our systematic comparison of biosynthetic costs described
previously in the literature (Tables 1 and 2) shows that most cost
measures are highly correlated with one another. Among
previously reported measures, molecular weight is the least
related (Figure 1), which is expected since the other cost estimates
are based on manual curation of metabolic networks. This
finding supports the view of Seligmann [7] that the molecular
weight of an amino acid may account for biosynthetic
investments not easily estimated from the metabolic network
alone. Of the two costs estimated using FBA in glucose limiting
conditions, our Aglucose cost measure correlates with those
previously described in the literature, confirming previous cost
measures and validating our systems approach to estimating
biosynthetic cost. One interesting point to note is that our Aglucose
cost measure, like all previously reported cost measures (with the
exception of Wagner’s fermentative measure [5]), predicts
tryptophan as being the most expensive amino acid to produce
(Table 1). Tryptophan may be expensive because of its complex
double ring structure and the number of high energy molecules
required for its synthesis.
The Rglucose cost measure shows little relationship with any
previously described cost metric under the same condition, and
may provide a novel perspective on how to measure the cost of
amino acid biosynthesis. The Rglucose cost shows leucine and
lysine to be the most expensive amino acids, whereas tryptophan
is estimated as one of the cheapest in contrast to other previously
reported cost measures (see above). Because our Rglucose cost
measure incorporates the amino acid requirement in the biomass
reaction, this cost measure reflects the effect on nutrient uptake
of a small relative increase or decrease as well as the usage of this
amino acid in the cell. Therefore although a tryptophan
molecule may be expensive to produce individually, its low
relative usage makes it cheaper to maintain overall at the cellular
level.
While it is clear that no single measure may fully capture all
aspects of amino acid biosynthesis cost, we believe our systems
biology approach has a number of advantages over previous
methods. Given a genome-scale model, our computationally
generated cost measures require no manual curation and allow
cost calculations that are more explicitly replicable than other
methods. Moreover, use of a computational model allows costs to
be calculated under a different combinations of nutrient
availability, permitting a more flexible approach to exploring
costs under different cellular and environmental conditions. We
also believe our approach takes into account a broader
representation of cellular state, including all simulated reactions
and metabolites, not just those in amino acid metabolism.
Furthermore, as more information is included in genome scale
models, the in silico predictions of amino acid cost may come to
more closely represent their true costs in vivo. In particular the
inclusion of thermodynamic constraints in the S. cerevisiae model, as
has been done in E. coli [22], would be of particular relevance to
explore in future work.
One drawback to our approach is that a species-specific
stoichiometric model must be available to perform the analysis.
This limitation may be important for relative costs, since they are
more variable across species (Supplementary File S3), presumably
because of their dependency on species specific amino acid usage
in the biomass reaction, but less so for absolute cost estimates since
they are highly correlated between divergent species such as S.
cerevisiae and E. coli. A second point to consider is that the FBA
estimated cost of an amino acid may be dependent on the
objective function used in the model, For example, we assume that
the S. cerevisiae growth strategy is to maximise biomass, or consider
other strategies such as maximising ATP yield. Work by Schuetz et
al. [23] suggests that the biological relevance of the FBA objective
function is dependent on the environment considered, and
research on this topic may present another avenue for further
study.
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method used to determine a flux solution. In this analysis we used
FBA to find the flux distribution that minimised nutrient uptake.
Other approaches however identify the solution that minimises the
amount of metabolic adjustment from another flux solution [24] or
minimising the number of on/off reactions between two solutions
[25]. An exhaustive analysis of amino acid cost estimation using
different optimisation methods may find differences in the costs
estimated using a systems biology approach. Our analysis makes
very small perturbations to biomass requirements and we
anticipate that different model optimisation methods will have a
much smaller effect on the model solutions compared with other
applications such as complete in silico gene knockouts [26,27].
Translational optimisation over biosynthetic cost
minimisation
In our analysis of the impact of cost on gene expression,
multivariate regression models explained approximately 40% of
variation in transcript and protein levels (Table 2). Of this variance
in protein and transcript levels, the majority is explained by
optimisation of the coding sequence for translation through codon
usage bias rather than cost minimisation. This conclusion that
biosynthetic cost may only be a weak selective force on S. cerevisiae
gene expression is similar to recent results by Raiford et al. [6].
However, by examining cost minimisation in combination with
features of translational optimisation such as codon bias, our
analysis extends the work of Raiford et al. [6] to demonstrate that
amino acid cost does appear to contribute a small effect on gene
expression, independent of codon usage bias (Table 2, Figure 2).
Our work also shows that the choice of cost type had only a small
effect on the variation explained by the regression models, which
may be expected given that the majority of the cost estimates are
correlated.
Costly amino acids evolve more slowly
Although biosynthetic cost may play only a minor role in terms
of gene expression, we found a strong negative correlation between
certain cost measures and rates of protein sequences evolution in
yeast, in particular for molecular weight, Akashi and Gojobori’s
energetic [2] or Aglucose costs (Table 3, Figure 3). Our results su-
ggest that expensive amino acids have a lower substitution rate and
are more likely to be conserved while cheaper ancestral amino
acids are more likely to be substituted even when controlling for
the substitution rate of the encoding gene. These results support
previous work in bacteria by Rocha and Danchin [28], who found
that biosynthetic cost plays a small role in predicting substitution
rates in E. coli and B. subtilis proteins, and by Hurst et al. [29], who
found a negative relationship between the average cost per
replacement and amino acid divergence. A possible hypothesis
based on these trends is that expensive amino acids are only used
for specific structural or functional roles and are therefore
conserved, while cheaper amino acids may be under weaker
structural or functional constraints and more likely to be
substituted. In contrast to analysis of gene expression in the
previous section, the trends observed between cost and substitution
rate are more dependent on which cost type is used. Our results
suggest that Aglucose cost was one of the better measures for
explaining variation in substitution rates (Table 3). Thus, a more
detailed and wide ranging systems biology investigation of different
environments may further help understand which type of amino
acid cost and nutrient availability explain patterns of protein
sequence evolution.
We are aware that the work presented here does not confirm
cost selection as a causal factor in explaining the correlation
between cost and rate of amino acid evolution, nor does it discount
the possibility that biosynthetic cost may be correlated with other
biochemical properties of amino acids that are thought to
influence the pattern of protein sequence evolution [30]. A further
point to consider is the method used to estimate the amino acid
substitution rates. We used the codeml software [31] to provide a
maximum likelihood estimate of amino acid substitution rate for
each site. This method requires an a priori expectation of the
relative rates of amino acid substitution in the form of a
substitution matrix. Here we used the Whelan and Goldman
(WAG) matrix [32], which was empirically estimated from
observed amino acid substitution events in a curated set of
homologs. Since differences in biochemical properties among
amino acids are reflected in the relative rate of substitution among
amino acids, it is possible that the correlations between cost and
substitution rate we observe may be an artifact of the selective
pressures that influence the substitution rates described in the
WAG matrix as opposed to the direct effect of cost minimisation
itself. We therefore attempted to control for this possibility by re-
estimating amino acid substitution rates using a null rate matrix
where rates of change between all amino acids were identical.
Using substitution rates estimated from this null rate matrix, we
observed the same trends between cost and substitution rate for
molecular weight (Spearman R ~{ 0:45, p ~ 0:048), Aglucose
(Spearman R ~{ 0:53, p ~ 0:016) and Rglucose (Spearman
R ~ 0:26, p ~ 0:28). These results indicate that the correlation
for either molecular weight or Aglucose with amino acid substitution
rates is not likely to be a spurious effect of other factors encoded by
mutation bias or selection in the substitution matrix.
Thus we conclude that biosynthetic cost may play a role in yeast
protein sequence evolution that should be considered alongside
other factors that have been demonstrated to correlate with rates
of amino acid substitution [33]. If cost minimisation does however
prove to be a selective force on protein sequence evolution and
amino acid biosynthetic costs vary considerably among groups or
organisms we hypothesise that rates of protein sequence evolution
may not follow universal trends across taxa. Moreover, it is clear
that rates of amino acid substitution can provide a powerful filter
for determining which measures of amino acid biosynthetic cost
might be most biologically relevant for other analyses, such as
effects on gene expression (see above). On these grounds, we may
tentatively conclude that the Aglucose cost captures the in vivo cost of
amino acid biosynthesis more accurately than other measures, and
Table 3. Correlation between amino acid substitution rate
and biosynthetic cost.
Cost type Rp
S. cerevisiae Aglucose 20.54 0.015
S. cerevisiae Rglucose 20.25 0.28
Akashi & Gojobori (2002) 20.47 0.034
Craig & Weber (1998) Energy 20.28 0.23
Craig & Weber (1998) Steps 20.19 0.43
Wagner (2005) Fermentative 20.32 0.17
Wagner (2005) Respiratory 20.4 0.077
Molecular Weight 20.46 0.04
Each row represents the Spearman’s Rank correlation between cost type and
the mean substitution rate normalised by the estimated tree length of the
encoding gene alignment for each of the twenty amino acids.
doi:10.1371/journal.pone.0011935.t003
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relevant representation of amino acid cost.
Conclusions
We have developed a novel systems-biology approach to
estimating the cost of amino acid biosynthesis and conducted a
systematic investigation of how amino acid biosynthetic cost has
shaped gene expression and protein evolution in yeast. Our
analysis indicates that amino acid biosynthetic cost plays a limited
role in transcript and protein production relative to what might be
expected, given that a predicted 80% [5] of the cellular ATP
budget is devoted to protein synthesis. Our results do reveal a
negative correlation with amino acid biosynthetic cost and rates of
amino acid substitution in Saccharomyces species, which may
highlight an important selective force governing molecular
evolution in yeast.
Materials and Methods
Simulating a genome scale model of metabolism
Each S. cerevisiae and E. coli genome scale model is a matrix
detailing the stoichiometry of a set of metabolic reactions
representing the ratios of metabolites consumed and produced
by each reaction. A species genome scale model matrix S is size
m|n where m is the total number of metabolites and n is the total
number of reactions. The position Sij in the matrix represents the
coefficient of metabolite i in reaction j. A positive coefficient
indicates the metabolite is produced, while a negative value
indicates the metabolite is consumed. A value of 0 means the
metabolite does not participate in the reaction.
Flux balance analysis of a genome scale model aims to solve the
equation S.v~0 using linear programming, where v is a vector of
predicted flux distributions (i.e. reaction rates) and is equal in
length to the number of reactions in the model. Multiple solutions
may exist for v and a biologically meaningful reaction is usually
optimised such as production of biomass or ATP. Additional
constraints may be placed on the model solution, for example that
a certain reaction flux may not be negative which then forces the
reaction to only proceed in the forward direction. Constraints on
the reactions that transport nutrients in and out of the model can
be used the simulate different combinations of nutrient availability.
A systems biology approach to estimating the cost of
amino acid synthesis
Flux balance analysis was performed using the COBRA toolbox
[34] and the lpsolve library [35], running in the MATLAB
environment. The genome scale models used were iND750 for S.
cerevisiae [26] and iJR904 for E. coli [12]. Reaction fluxes are
measured in mmol of metabolite, per gram dry weight of biomass,
per hour (mmol{1 gDW{1 hr{1). Metabolite concentrations are
measured in mmol of nutrient per gram of dry weight biomass
(mmol{1 gDW{1). The rate of the biomass production reaction,
synonymous with cellular growth, is measured per hour (hr{1).
For each of the twenty amino acids in the model biomass
reaction we increased or decreased the stoichiometric requirement
of the amino acid at position Sij where i is the amino acid and j is
the biomass reaction. The change in amino acid requirement
ranged from +0:00002 mmol{1 gDW{1 for absolute estimations
of amino acid cost and +0:0002% for the relative estimates of
cost.
For each change in amino acid requirement, biomass
production flux was fixed and the model solved to minimise the
flux entering the cell for one of three nutrients: glucose, ammonia,
sulphate. The other nutrient entry reactions in the model (water
and oxygen) were not considered as objective functions. Each
nutrient transport reaction was set to have a lower boundary of
{10,000 mmol{1 gDW{1 hr{1 to effectively make the allow-
able entry of the nutrient into the cell limitless. When estimating a
cost for a given nutrient it is important to note there were no other
equivalent nutrient sources entering the cell. For example, glucose
transport was the only source of high energy sugar and ammonia
was the only source of nitrogen.
Using data points produced from the above series of FBA
simulations, the absolute cost for each amino acid was derived as
the slope between the absolute change in amino acid requirement
and the corresponding effect on nutrient uptake flux. Likewise, the
relative cost was estimated from the percentage change in amino
acid requirement and the effect on nutrient uptake flux. As noted
above, the amino acid requirement for growth is defined as
millimoles per gram of dry weight biomass (mmol{1 gDW{1) and
the supply of nutrients into the cell is defined as the per hour entry
of each molecule (mmol{1 gDW{1 hr{1). Thus, the units of
absolute cost are per hour change (hr{1) and the units of relative
cost are mmol{1 gDW{1 hr{1.
All costs were estimated at a range of growth rate fluxes:
0:1 hr{1, 0:2 hr{1 and 0:3 hr{1. After estimation each cost was
rescaled by dividing by the growth rate at which it was estimated.
Dividing each cost by the growth rate changed the units of
our cost measures, resulting in the relative costs becoming
mmol{1 gDW{1 and the absolute costs becoming unitless. The
MATLAB code used for the estimation of amino acid cost is
available in Supplementary File S7. The R code used to compare
the different amino acid cost types in Figure 1 is available in
Supplementary File S8.
Relationship between absolute and relative cost
estimates
The absolute cost estimates can be defined mathematically as
the differential between changes in amino acid requirement (x) and






The relative estimate of amino acid cost can be defined as the
differential of a percentage change in amino acid requirement (r)
and the corresponding effect on nutrient uptake (U). Shown in the
Figure 3. Comparison of amino acid substitution rate with biosynthetic cost. Each point is the mean substitution rate for one of the twenty
standard amino acids. Substitution rates were estimated from alignments of Saccharomyces genes by Wall et al. [36]. Each amino acid substitution
rate was normalised by tree length and then averaged across all alignment columns corresponding to the amino acid at that site in the ancestral
protein sequence. Alignment columns containing gaps were excluded. The standard error of the mean for each amino acid substitution rate is shown
as a bar in each point. Robust linear regression and 95% confidence intervals are used to indicated trend. Each plot indicates the Spearman’s rank
correlation between amino acid substitution rate and biosynthetic cost.
doi:10.1371/journal.pone.0011935.g003
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These two equations illustrate that an absolute estimate of
amino acid cost can be scaled to a relative cost through
multiplication by x representing the stoichiometry of the given
amino acid in the biomass reaction. This reverse is true where a
relative cost can be scaled to an absolute cost by division. In
addition to showing this theoretically we also demonstrated these
results empirically (results not shown).
Determination of transcript and protein characteristics
The Codon Adaptation Index (CAI) for each S. cerevisiae gene
was taken from Wall et al. 2005 [36], and the number of genomic
tRNA copies for each amino acid was taken from Akashi [15]. The
total number of tRNAs were summed over the length of the
protein, and then divided by the length of the protein to give a
mean number of tRNAs per residue for each gene. Previously
reported amino acid biosynthetic costs were obtained from Craig
and Weber [1], Akashi and Gojobori [2], Wagner [5] and
Seligmann [7]. For each gene, the average tRNA gene number,
biosynthetic cost, or atomic content was computed as the sum of
the count or cost over the encoded protein divided by the length
excluding stop codons. Prior to regression, each of these variables
was transformed by the natural logarithm then scaled to have the
same mean and variance. Scaling was performed by subtracting
the mean then dividing by the root mean square for each variable.
The aim of this was to reduce any over-variation and
heteroscedasticity biasing fit estimation.
Modelling the effects of biosynthetic cost on gene
expression
Multiple regression was used to measure the importance of
biosynthetic cost on transcript and protein expression using the R
statistical computing language [37]. The measured quantities of
either transcript or protein levels were treated as the response
variable and biosynthetic cost, CAI and atomic content were used
as explanatory variables. Atomic content consisted of three
independent variables: carbon, nitrogen and sulphur content.
Experimental conditions that differed among replicates were
treated as fixed effects in the regression, and included as
interaction terms. Initially, all possible interaction terms were
considered and automated step-wise regression used to remove
superfluous interaction terms based on a penalised log-likelihood
score – Akaike’s Information Criterion (AIC) [18].
To estimate the importance of each of the equation parameters,
the data was regressed without the variable in question, and then
compared to the regression containing all terms, again using AIC.
For example, to estimate the importance of nitrogen in the
Castrillo et al. 2007 [11] transcript data, the regression was first
fitted using all factors - environment, dilution rate, CAI, tRNA
gene number, biosynthetic cost, nitrogen, carbon and sulphur
content. The importance of nitrogen was then determined by
repeating the regression fitting with the same variables except
nitrogen content. The contribution of nitrogen content to explain
the variation was then estimated from the difference in the
regression without nitrogen compared with the regression
containing all terms. This process was performed for all factors
in the equation, and then repeated for all biosynthetic cost
estimates as the cost variable in the equation. The R code used to
plot the the regression results in Figure 2 is available in
Supplementary File S8.
Gene expression data
The experimental transcriptomic data used in this analysis are
from Castrillo et al. 2007 [11] and the proteomic dataset was
produced by Ghaemmaghami et al. 2003 [21]. Briefly, the Castrillo
et al. 2007 [11] experiments continuously cultured S. cerevisiae using
a chemostat under four nutrient limiting conditions and three
dilution rates, for a total of twelve different experimental
conditions. Transcript levels were estimated from replicate
microarray analysis of total RNA which was then processed by
robust multi-array (RMA) quantile normalisation [38]. The
tabulated transcript data used in this analysis are available in
Supplementary File S4.
Protein data produced by Castrillo et al. [11] measured up/
down regulation of a protein against a background, which is not
suitable as a measure of absolute protein expression levels.
Therefore, we used data from Ghaemmaghami et al. 2003 [21]
for our analyses of cost in protein production. The protein data
was produced from tandem affinity purification (TAP) of TAP-
tagged S. cerevisiae ORFs. Expression levels for each protein were
determined using antibody-tag based quantification. These data
were converted to absolute protein molecules per cell using a
purified E. coli INFA-TAP construct standardised against the
range of yeast TAP tag protein observations. The tabulated
protein data used in this analysis are available in Supplementary
File S5.
For the model analysis, protein levels were transformed by the
natural logarithm then scaled. Transcript levels were scaled, but
not log transformed as this was done in the original processing.
Estimation of amino acid substitution rates
Codon-based nucleotide alignments of coding regions from
orthologs of S. cerevisiae, S. mikatae, S. bayanus, and S. paradoxus genes
were taken from Wall et al. [36]. Alignments containing less than
four species or where the S. cerevisiae sequence did not match the
SGD reference sequence [39] were ignored.
The relative substitution rate and ancestral state of each
alignment column was estimated using codeml [31] with the
Whelan and Goldman (WAG) amino acid substitution rate matrix
[32]. The codeml parameters used were as follows: fix_kappa, 0;
seqtype, 3; aaDist, 0; Malpha, 0; kappa, 2; cleandata, 0; ncatG, 8;
model, 3; method, 0; fix_omega, 0; getSE, 0; RateAncestor, 1;
omega, 0.4; NSsites, 0; verbose, 1; fix_blength, 21; icode, 0;
fix_alpha, 0; CodonFreq, 2; alpha, 0.5; Mgene, 0; clock, 0. The
Newick representation of species tree used was: ((S. cerevisiae, S.
paradoxus) S. mikatae, S. bayanus).
The substitution rate for each alignment column was divided by
the codeml estimated alignment tree length to control for the
mutation rate of the encoding gene. The single gene alignment
with an estimated tree length of 0 was removed from the data. The
ancestral amino acid at each alignment column was inferred and
the substitution rate of all alignment columns was averaged over
all sites where the same ancestral amino acid was observed. Sites
that contained a gap in the any of the descendant sequences were
ignored. The tabulated substitution rate data used in this analysis
are available as Supplementary File S6. The R code used to plot
substitution rate versus biosynthetic cost in Figure 3 is available as
Supplementary File S8.
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File S1 Amino acid costs. Amino acid cost estimates used in the
analysis.
Found at: doi:10.1371/journal.pone.0011935.s001 (0.00 MB ZIP)
File S2 Amino acid cost correlations. Spearman’s rank correla-
tions between cost estimates. The first 18 rows are R values, and
the latter 18 rows are p values.
Found at: doi:10.1371/journal.pone.0011935.s002 (0.00 MB ZIP)
File S3 Comparison of the genome scale model derived cost data
sets. Comparison of FBA estimated amino acid cost with Akashi
and Gojobori cost (left), and molecular weight (right). Both S.
cerevisiae and E. coli measures are included to illustrate correlation
of cost estimates between species. Estimated cost values have been
rescaled around their mean value to allow comparisons across
species. Trend lines are indicated using ‘‘loess’’ smoothing.
Found at: doi:10.1371/journal.pone.0011935.s003 (0.02 MB EPS)
File S4 Tabulated transcript data set. The transcript data from
Castrillo et al. 2007 tabulated with cost, atomic composition, tRNA
gene number and CAI.
Found at: doi:10.1371/journal.pone.0011935.s004 (5.68 MB ZIP)
File S5 Tabulated protein data set. The protein data from
Ghaemmaghami et al. 2003 tabulated with cost, atomic compo-
sition, tRNA gene number and CAI.
Found at: doi:10.1371/journal.pone.0011935.s005 (0.68 MB ZIP)
File S6 Tabulated amino acid substitution rate data. Substitu-
tion rate estimates at each position in 3334 of the Saccharomyces
species alignments produced by Wall et al.
Found at: doi:10.1371/journal.pone.0011935.s006 (4.20 MB ZIP)
File S7 MATLAB code to estimate amino acid cost. The
MATLAB and COBRA code used to estimate amino acid cost.
Found at: doi:10.1371/journal.pone.0011935.s007 (0.01 MB ZIP)
File S8 The R code used to generate the figures presented in this
work.
Found at: doi:10.1371/journal.pone.0011935.s008 (7.94 MB ZIP)
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